Cargando…
Purine nucleoside phosphorylase inhibitors - an immunotherapy with novel mechanism of action for the treatment of melanoma
Autor principal: | Bantia, Shanta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649482/ http://dx.doi.org/10.1186/2051-1426-3-S2-P292 |
Ejemplares similares
-
Design, Synthesis,
Biological Evaluation, and Crystallographic
Study of Novel Purine Nucleoside Phosphorylase Inhibitors
por: Skácel, Jan, et al.
Publicado: (2023) -
Purine nucleoside phosphorylase is associated with centrioles and basal bodies
Publicado: (1981) -
Conservation of structure and activity in Plasmodium purine nucleoside phosphorylases
por: Chaikuad, Apirat, et al.
Publicado: (2009) -
Purine nucleoside phosphorylase enables dual metabolic checkpoints that prevent T cell immunodeficiency and TLR7-associated autoimmunity
por: Abt, Evan R., et al.
Publicado: (2022) -
Purine nucleoside phosphorylase deficiency in two unrelated Saudi patients
por: Alangari, Abdullah, et al.
Publicado: (2009)